Literature DB >> 326177

Enzymes as drugs.

J S Holcenberg.   

Abstract

Mesh：

Substances：

Year:  1977        PMID： 326177     DOI： 10.1146/annurev.pa.17.040177.000525

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  4 in total

Review 1.  Pharmacokinetic/pharmacodynamic relationships of asparaginase formulations: the past, the present and recommendations for the future.

Authors:  Vassilios I Avramis; Eduard H Panosyan
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Comparison of native E. coli and PEG asparaginase pharmacokinetics and pharmacodynamics in pediatric acute lymphoblastic leukemia.

Authors:  J C Panetta; A Gajjar; N Hijiya; L J Hak; C Cheng; W Liu; C H Pui; M V Relling
Journal:  Clin Pharmacol Ther       Date:  2009-09-09       Impact factor: 6.875

3.  Isolation and characterization of a Chlamydomonas L-asparaginase.

Authors:  J H Paul
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

Review 4.  Recent Strategies for the Immobilization of Therapeutic Enzymes.

Authors:  Chen-Yuan Zhu; Fei-Long Li; Ye-Wang Zhang; Rahul K Gupta; Sanjay K S Patel; Jung-Kul Lee
Journal:  Polymers (Basel)       Date:  2022-03-30       Impact factor: 4.329
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.